Dr Juneja and Dr. Patt discuss the financial implications of AI adoption, how tools like ambient listening and real-time monitoring can enhance patient care, and the role of AI in educating patients to manage treatment toxicities. Plus, they dive into the advancements in drug discovery and clinical trials, where AI is paving the way for more efficient and personalized therapies.
- - - For a summary and key takeaways, visit: https://xcures.com/ai-and-healthcare/...
- - -TimeStamps - - - -
00:00 Introduction
01:36 Real-Time Monitoring in Cancer Care
05:25 The Future of AI in Drug Discovery
08:31 Optimizing Clinical Trials with AI
- - -
#aiandhealthcare #artificialintelligence #aiinhealthcare
🔴Like, Subscribe, and Share to see more of this type of content!
— ABOUT AI AND HEALTHCARE —
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine. Discover how AI is transforming healthcare today, addressing real-world challenges and improving patient outcomes.
This series caters to anyone's listening style with bite-sized, commute-friendly insights and full-length interviews. Join co-hosts Mika Newton, CEO of xCures, and Dr. Sanjay Juneja, a globally recognized oncologist and AI thought leader at Tempus AI, as they explore cutting-edge innovations with industry pioneers.
— ABOUT DR DEBRA PATT —
Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics driving digital healthcare tool adoption in clinical practice to improve the patient journey.
She is the managing partner for the central Texas, Gulf, and Rio Grande Valley regions in Texas Oncology since 2023.
Dr. Patt is the medical director for public policy for The US Oncology Network and has testified before the US Congress and Senate to protect access to care for cancer patients. She has chaired the council on legislation and the cancer committee for the Texas Medical Association.
Dr. Patt serves as the current vice president of the Community Oncology Alliance and on the ASCO Board of Directors. She also chairs the Artificial Intelligence Task Force for ASCO and is the liaison for the clinical innovation committee.
She lectures medical students and is a professor at Dell Medical School at The University of Texas at Austin.
— ABOUT DR SANJAY JUNEJA —
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 20 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim.
His debut podcast, Target Cancer: Podcast, amassed over 3 million downloads in more than 100 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests. He currently serves as the VP of Clinical AI Operations at Tempus AI. / sanjayjunejamd
— ABOUT MIKA NEWTON —
With over 25 years of leadership experience in life sciences, Mika Newton is the CEO of xCures, a health technology company that has created an AI-enabled, medical records data structuring platform.
Mika is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and has a proven track record of bringing transformative technologies to market and fostering innovation. / mikanewton
Additional listening channels, at xcures.com/ai-and-healthcare
Views expressed by Dr. Juneja, Mr Newton, and guests are solely their own and are not attributable to xCures, Tempus, or any of our guests' affiliations.
Информация по комментариям в разработке